CDKN2A and Splenomegaly: They reported that complete loss of CDKN2A accelerated leukemogenesis in HMGA1 transgenic mice that showed marked splenomegaly and significantly decreased OS compared with HMGA1 transgenic/CDKN2A WT mice.